The outlook for the Singapore economy is expected be clouded by global economic and political uncertainties. The MAS’ (Monetary Authority of Singapore) twice-yearly review expects domestic drivers to support the slower growth of the economy.

Healthcare services is one of these domestic drivers – its fast-growth underpinned by an aging population and rising disposable incomes.

On SGX, there are about 30 healthcare stocks and they run the gamut from producers of disposable medical consumables, to chains of GP clinics, medical specialists and biotech start-ups.

The net profit margin (NPM) of the different categories of healthcare stocks varies widely and is one of the significant factors affecting their share price performance. The top six by NPM have all outperformed the Catalist Index- and all are Catalist-listed.

This post was originally posted here, by our partner website

Table 1: The four categories of SGX healthcare stocks

*Data as at Apr 16, 2019